Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Lori

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Chinese Medical Journal|October 18, 2006
CD4+ T cell-mediated presentation of non-infectious HIV-1 virion antigens to HIV-specific CD8+ T cellsJian-qing Xu, Franco Lori, Julianna Lisziewicz
Expert Review of Vaccines|August 3, 2004
APC-targeted immunization for the treatment of HIV-1Franco Lori, Laurene M Kelly, Julianna Lisziewicz
AIDS (London, England)|September 28, 2002
Quantification of HIV-specific CD8 T cells by in vitro stimulation with inactivated viral particlesJianqing Xu, Lucia Whitman, Franco Lori, et al.
Drug Safety|June 20, 2003
Hydroxyurea in the treatment of HIV infection: clinical efficacy and safety concernsJulianna Lisziewicz, Andrea Foli, Mark Wainberg, et al.
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|November 8, 2002
Gene therapy approaches to HIV infectionFranco Lori, Paola Guallini, Luca Galluzzi, et al.
AIDS Research and Human Retroviruses|February 28, 2002
Methods of using interleukin 2 to enhance HIV-specific immune responsesJianqing Xu, Lucia Whitman, Franco Lori, et al.
The Journal of Gene Medicine|April 5, 2002
High efficiency lentiviral gene delivery in non-dividing cells by deoxynucleoside treatmentElisabetta Ravot, Giuditta Comolli, Franco Lori, et al.
The Journal of Infectious Diseases|October 9, 2007
A checkpoint in the cell cycle progression as a therapeutic target to inhibit HIV replicationAndrea Foli, Maria Angela Maiocchi, Julianna Lisziewicz, et al.
Expert Opinion on Drug Safety|July 23, 2004
Safety of hydroxyurea in the treatment of HIV infectionFranco Lori, Laurene M Kelly, Andrea Foli, et al.
Vaccine|February 13, 2007
Induction of HIV-specific memory T-cell responses by topical DermaVir vaccineSandra A Calarota, David B Weiner, Franco Lori, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Chinese Medical Journal|October 18, 2006
CD4+ T cell-mediated presentation of non-infectious HIV-1 virion antigens to HIV-specific CD8+ T cellsJian-qing Xu, Franco Lori, Julianna Lisziewicz
Expert Review of Vaccines|August 3, 2004
APC-targeted immunization for the treatment of HIV-1Franco Lori, Laurene M Kelly, Julianna Lisziewicz
AIDS (London, England)|September 28, 2002
Quantification of HIV-specific CD8 T cells by in vitro stimulation with inactivated viral particlesJianqing Xu, Lucia Whitman, Franco Lori, et al.
Drug Safety|June 20, 2003
Hydroxyurea in the treatment of HIV infection: clinical efficacy and safety concernsJulianna Lisziewicz, Andrea Foli, Mark Wainberg, et al.
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|November 8, 2002
Gene therapy approaches to HIV infectionFranco Lori, Paola Guallini, Luca Galluzzi, et al.
AIDS Research and Human Retroviruses|February 28, 2002
Methods of using interleukin 2 to enhance HIV-specific immune responsesJianqing Xu, Lucia Whitman, Franco Lori, et al.
The Journal of Gene Medicine|April 5, 2002
High efficiency lentiviral gene delivery in non-dividing cells by deoxynucleoside treatmentElisabetta Ravot, Giuditta Comolli, Franco Lori, et al.
The Journal of Infectious Diseases|October 9, 2007
A checkpoint in the cell cycle progression as a therapeutic target to inhibit HIV replicationAndrea Foli, Maria Angela Maiocchi, Julianna Lisziewicz, et al.
Expert Opinion on Drug Safety|July 23, 2004
Safety of hydroxyurea in the treatment of HIV infectionFranco Lori, Laurene M Kelly, Andrea Foli, et al.
Vaccine|February 13, 2007
Induction of HIV-specific memory T-cell responses by topical DermaVir vaccineSandra A Calarota, David B Weiner, Franco Lori, et al.
Pageof 5